Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Weingartner

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Life Sciences|December 28, 1981
Vasopressin treatment of cognitive dysfunction in progressive dementiaH Weingartner, W Kaye, P Gold, et al.
Archives of General Psychiatry|April 1, 1974
Marihuana and social behavior; a controlled studyM Galanter, R Stillman, R J Wyatt, et al.
Science (New York, N.Y.)|May 26, 1972
Effects on humans of 9 -tetrahydrocannabinol administered by smokingM Galanter, R J Wyatt, L Lemberger, et al.
Archives of General Psychiatry|August 1, 1980
Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal menJ L Rapoport, M S Buchsbaum, H Weingartner, et al.
Archives of General Psychiatry|August 1, 1986
Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of dosesP N Tariot, T Sunderland, H Weingartner, et al.
Psychopharmacology Bulletin|January 1, 1985
Low- and high-dose naloxone in dementia of the Alzheimer typeP N Tariot, T Sunderland, H Weingartner, et al.
Science (New York, N.Y.)|February 3, 1978
Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boysJ L Rapoport, M S Buchsbaum, T P Zahn, et al.
Lancet (London, England)|November 14, 1981
Behavioural effects after high dose naloxone administration to normal volunteersM R Cohen, R M Cohen, D Pickar, et al.
Archives of General Psychiatry|May 1, 1987
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response studyT Sunderland, P N Tariot, R M Cohen, et al.
Psychopharmacology Bulletin|January 1, 1985
Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controlsT Sunderland, P N Tariot, E A Mueller, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Life Sciences|December 28, 1981
Vasopressin treatment of cognitive dysfunction in progressive dementiaH Weingartner, W Kaye, P Gold, et al.
Archives of General Psychiatry|April 1, 1974
Marihuana and social behavior; a controlled studyM Galanter, R Stillman, R J Wyatt, et al.
Science (New York, N.Y.)|May 26, 1972
Effects on humans of 9 -tetrahydrocannabinol administered by smokingM Galanter, R J Wyatt, L Lemberger, et al.
Archives of General Psychiatry|August 1, 1980
Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal menJ L Rapoport, M S Buchsbaum, H Weingartner, et al.
Archives of General Psychiatry|August 1, 1986
Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of dosesP N Tariot, T Sunderland, H Weingartner, et al.
Psychopharmacology Bulletin|January 1, 1985
Low- and high-dose naloxone in dementia of the Alzheimer typeP N Tariot, T Sunderland, H Weingartner, et al.
Science (New York, N.Y.)|February 3, 1978
Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boysJ L Rapoport, M S Buchsbaum, T P Zahn, et al.
Lancet (London, England)|November 14, 1981
Behavioural effects after high dose naloxone administration to normal volunteersM R Cohen, R M Cohen, D Pickar, et al.
Archives of General Psychiatry|May 1, 1987
Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response studyT Sunderland, P N Tariot, R M Cohen, et al.
Psychopharmacology Bulletin|January 1, 1985
Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controlsT Sunderland, P N Tariot, E A Mueller, et al.
Pageof 16